ENOV vs INCY · rev $1.17B vs P/E 14, rev $5.14B
Enovis Corp (ENOV) versus Incyte Corporation (INCY) — a side-by-side from cached financials, not a winner call.
Enovis Corp (ENOV) is a medical devices company listed on US.
Incyte Corporation (INCY) is a biotechnology company listed on US.
Latest reported ENOV revenue for 2026-07-03 was $1.17B. Net income was -$10.0M. Revenue was up 98.9% from 2026-04-03 to 2026-07-03. ENOV currently screens at market cap $1.37B.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
ENOV currently screens at market cap $1.37B. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Not investment advice. Open the ENOV and INCY stock pages for the full models.
Not investment advice.